Subscribe
shutterstock_1486264271_jhvephoto
JHVEphoto / Shutterstock.com
20 July 2021Big PharmaAlex Baldwin

PTAB invalidates Medytox Botox patent

The Patent Trial and Appeal Board (PTAB) has ruled that a Medytox patent for its wrinkle treatment should not have been granted.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
US appeals court upholds decision on wrinkle treatment
29 June 2023   Board did not violate procedure regarding ‘preliminary guidance’ say Federal Circuit judges | Medytox’s substitute claims found to be ‘unpatentable’.
article
USITC to investigate botox imports
3 May 2022   The US International Trade Commission has agreed to investigate imports of botulinum toxin products following a complaint that they infringe trade secrets.
Americas
Allergan sued for promoting off-label Botox use
20 April 2015   An Ontario-based company has sued Allergan for allegedly infringing a method patent that protects the use of cosmetic drug Botox to treat back pain.


Editor's picks

Why US patent reform is ‘essential’ for US economic prosperity and security
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025

Editor's picks

Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025
Americas
Patent attorneys by day, coders by night: Sterne Kessler launches ‘homemade’ AI assistant
3 April 2025
Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025
Americas
‘We need the top 50 law firms to stand up’: Will Perkins Coie ignite Trump resistance?
13 March 2025

More on this story

Big Pharma
US appeals court upholds decision on wrinkle treatment
29 June 2023   Board did not violate procedure regarding ‘preliminary guidance’ say Federal Circuit judges | Medytox’s substitute claims found to be ‘unpatentable’.
article
USITC to investigate botox imports
3 May 2022   The US International Trade Commission has agreed to investigate imports of botulinum toxin products following a complaint that they infringe trade secrets.
Americas
Allergan sued for promoting off-label Botox use
20 April 2015   An Ontario-based company has sued Allergan for allegedly infringing a method patent that protects the use of cosmetic drug Botox to treat back pain.

More on this story

Big Pharma
US appeals court upholds decision on wrinkle treatment
29 June 2023   Board did not violate procedure regarding ‘preliminary guidance’ say Federal Circuit judges | Medytox’s substitute claims found to be ‘unpatentable’.
article
USITC to investigate botox imports
3 May 2022   The US International Trade Commission has agreed to investigate imports of botulinum toxin products following a complaint that they infringe trade secrets.
Americas
Allergan sued for promoting off-label Botox use
20 April 2015   An Ontario-based company has sued Allergan for allegedly infringing a method patent that protects the use of cosmetic drug Botox to treat back pain.

More features

AstraZeneca to appeal invalidated diabetes patent in generics dispute
Why US patent reform is ‘essential’ for US economic prosperity and security
Medical company sees $452m trade secrets award cut by 87%
Fed Circ: Generic doesn’t infringe Metacel MS drug
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
Strategic IP protection for biotech-related GenAI
South Korean firm sues in UK over CRISPR/Cas9 blood disorder drug
Patent litigator with biotech and medical device background joins Sterlington